Skip to content

Clinical trials

Completed Phase 1/2 Glioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 1/2 Status: Completed Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20023
20031
20054
20062
20081
20093
20104
20116
20124
20131
20145
20156
20163
20172
20183
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
Duke University3
Celgene2
Dana-Farber Cancer Institute2
Eli Lilly and Company2
INSYS Therapeutics Inc2
M.D. Anderson Cancer Center2
AHS Cancer Control Alberta1
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma65
Glioblastoma40
Brain Neoplasms30
Astrocytoma25
Gliosarcoma18
Oligodendroglioma16
Central Nervous System Neoplasms15
Medulloblastoma6
Ependymoma5
Diffuse Intrinsic Pontine Glioma4

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.